Pulmonx Corp reports results for the quarter ended in December - Earnings Summary

Pulmonx

22/02/2023 22:02

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 38
cents​​ per share for the quarter ended in December. The mean
expectation of seven analysts for the quarter was for a loss
of 42 cents per share.
    * Revenue rose 12.5% to $15.43 million from a year ago;
analysts
expected $13.98 million. 
    * Pulmonx Corp's reported EPS for the quarter was a loss
of 38
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulmonx Corp shares had risen by 3.4% this quarter.
    * The company reported a quarterly loss of $14.28 million.
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
22 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.42          -0.38          Beat
 Sep. 30 2022      -0.40          -0.38          Beat
 Jun. 30 2022      -0.41          -0.40          Beat
 Mar. 31 2022      -0.37          -0.43          Missed